Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP185150.RAUauruxwMSj1guF8wRWrf1m9eeb36pMzmeQzPVVF324Q130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP185150.RAUauruxwMSj1guF8wRWrf1m9eeb36pMzmeQzPVVF324Q130_provenance.
• NP375217.RAfsOJHE4O6yHP5V2ckTvLpEUCfOOqCN_ozE69kiV-ruI130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP375217.RAfsOJHE4O6yHP5V2ckTvLpEUCfOOqCN_ozE69kiV-ruI130_provenance.
• NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP555564.RAkTMuFCdWtAs0GEItHr-LLpXXnyblRRk9rVcqjQ2V8Go130_provenance.
• NP635053.RAcnJT3nNoqMF8X0xoPFUiJJz8Ka89djOgNOHZHLNqDug130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP635053.RAcnJT3nNoqMF8X0xoPFUiJJz8Ka89djOgNOHZHLNqDug130_provenance.
• NP723585.RAUsMj-QEeRFkMMlXpAoTFKVuWP-jAZ2zsuL1LDRXwpVU130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723585.RAUsMj-QEeRFkMMlXpAoTFKVuWP-jAZ2zsuL1LDRXwpVU130_provenance.
• NP250574.RAeyS4KCNA2oWc66jQlbH8EU6L1jiEOV0R2Qagpscvhfc130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP250574.RAeyS4KCNA2oWc66jQlbH8EU6L1jiEOV0R2Qagpscvhfc130_provenance.
• NP363703.RAQvqsabG3ElXy6mA0ATvXM1RV8os5jpeF5lJB_lX2v7k130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363703.RAQvqsabG3ElXy6mA0ATvXM1RV8os5jpeF5lJB_lX2v7k130_provenance.
• NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP747205.RAR2nivuBxWUXjigGvPJd4hZdk6cVUw4HIRdILjA1S0j0130_provenance.
• NP410373.RAtbBApgwyUdUelhvVzvvcpYtjOZaoTk5kbypNikgnzgU130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP410373.RAtbBApgwyUdUelhvVzvvcpYtjOZaoTk5kbypNikgnzgU130_provenance.
• NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888372.RAhqIZ6rNrQBYonLPm9W4D-tQpn5P09lalXE50-AR73bU130_provenance.
• NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658000.RApKkFFAKaA0_0Us3bmmjyWpuZjaDez8WafHsZQhz7Ihs130_provenance.
• NP387276.RA6Io4tLclSVZpYJi5TRQkZ6QwZ8EJplkToBgnbH7HNHo130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP387276.RA6Io4tLclSVZpYJi5TRQkZ6QwZ8EJplkToBgnbH7HNHo130_provenance.
• NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680174.RAoVvtMcpIFEJZpo0Vx2kFSUGuDlU9_RanfIEVCUS9w-k130_provenance.
• NP776340.RAAibmSFGsxEKXhHx6AjQWAD-0han0ubef5iJ6AgCQ04A130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776340.RAAibmSFGsxEKXhHx6AjQWAD-0han0ubef5iJ6AgCQ04A130_provenance.
• NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776350.RAB7NDFoW0S6GFS2387XiYxopgY3-PnbBBMBTG61XeFqY130_provenance.
• NP776355.RAAJBvHWwJK9HSW_GKdaO1IKQk3dwJmiLePWXEtGWywtA130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776355.RAAJBvHWwJK9HSW_GKdaO1IKQk3dwJmiLePWXEtGWywtA130_provenance.
• NP776329.RA1T0lxZFoAgXvvLOrILGI94kfFteAU2MR9IM3oT5S8zc130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776329.RA1T0lxZFoAgXvvLOrILGI94kfFteAU2MR9IM3oT5S8zc130_provenance.
• NP776345.RA3VFRJc93Dv-qqea-KhcuK9F-wieHEcRKQ9651p_mLU4130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776345.RA3VFRJc93Dv-qqea-KhcuK9F-wieHEcRKQ9651p_mLU4130_provenance.
• NP776331.RAU9MFU5GjvVK_w2ALknjKtFCBypxBa-AC7VDCC40ehH8130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776331.RAU9MFU5GjvVK_w2ALknjKtFCBypxBa-AC7VDCC40ehH8130_provenance.
• NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776348.RAbv6XZY1KK_bOLwWsq38Vgx0VJ3ezs-XTVa7X4p9yk0o130_provenance.
• NP776352.RAUd4RpiJ_-L_eFViAk8EAe0dj10FwDFIOl7ABPTqAyXo130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776352.RAUd4RpiJ_-L_eFViAk8EAe0dj10FwDFIOl7ABPTqAyXo130_provenance.
• NP776334.RAOl-CBdus1L1GfNBN1LZmWeLa3PiTN3Ge5n7_Bg-Mr68130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776334.RAOl-CBdus1L1GfNBN1LZmWeLa3PiTN3Ge5n7_Bg-Mr68130_provenance.
• NP776337.RANHoMTjVM1BxegiFhdzg5AqF8CR51zt1wrZ_kdvdC4_I130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776337.RANHoMTjVM1BxegiFhdzg5AqF8CR51zt1wrZ_kdvdC4_I130_provenance.
• NP776343.RAG7LVjd5nGZluhPIGhIPyjb0HzBJwzfITQKPBw_cscwg130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776343.RAG7LVjd5nGZluhPIGhIPyjb0HzBJwzfITQKPBw_cscwg130_provenance.
• NP776344.RAPptsDza45HGii7Qvu_NJee0rG_3ySvQ1Lt0_zJANMYY130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776344.RAPptsDza45HGii7Qvu_NJee0rG_3ySvQ1Lt0_zJANMYY130_provenance.
• NP776353.RAEL18D4DcW-75m05jyAVWy5aAZrgqhzQ5DsuepgPHOjE130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776353.RAEL18D4DcW-75m05jyAVWy5aAZrgqhzQ5DsuepgPHOjE130_provenance.
• NP776354.RAO2XSvcJF8JS4FZ_hk__xtMcIgNyAmM-l_f1PaR9ycoM130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776354.RAO2XSvcJF8JS4FZ_hk__xtMcIgNyAmM-l_f1PaR9ycoM130_provenance.
• NP776330.RAsAX79_xnjSAU57lqkl9t3e-S-PPvq3wu4DK968hs7XU130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776330.RAsAX79_xnjSAU57lqkl9t3e-S-PPvq3wu4DK968hs7XU130_provenance.
• NP776332.RAiH4iL28bULwvWec0NyTcMMbT5V0nLKxqAnRZiOCOpl0130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776332.RAiH4iL28bULwvWec0NyTcMMbT5V0nLKxqAnRZiOCOpl0130_provenance.
• NP776336.RAinLjTtT4kdf-v6K05daY1ZU_Ihsq7oYcrDTq_h5ezNM130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776336.RAinLjTtT4kdf-v6K05daY1ZU_Ihsq7oYcrDTq_h5ezNM130_provenance.
• NP776342.RAh8_Txn7UVS4e0xF6SEwd7XfDeMJHZcFxVnfRS6zG8G8130_assertion description "[Because most ER-negative breast tumors express mutant p53, our results provide the foundation for future development of p38 inhibitors to target p38 for the treatment of p53 mutant and ER-negative breast cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP776342.RAh8_Txn7UVS4e0xF6SEwd7XfDeMJHZcFxVnfRS6zG8G8130_provenance.